Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade.
性状
Solid
IC50 & Target[1][2]
Human COX-2
1.3 nM (IC50, in CHO cells)
Human COX-1
4 nM (IC50, in CHO cells)
Ovine COX-2
0.84 μM (IC50)
Ovine COX-1
5.1 μM (IC50)
体外研究(In Vitro)
Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC50 of 7±3 nM.
Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner.
Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay
Cell Line:
Neural stem cells (NSCs)
Concentration:
1, 3, 10, 30, 60 μM
Incubation Time:
1 day
Result:
Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM.
Western Blot Analysis
Cell Line:
Neural stem cells (NSCs)
Concentration:
10, 30 or 60 μM
Incubation Time:
6 hours
Result:
The activation of caspase-3 was increased in a concentration-dependent manner.
体内研究(In Vivo)
Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days.
Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
Male Sprague-Dawley rats (150±200 g)
Dosage:
3 mg/kg
Administration:
Oral administration, b.i.d., for 5 days
Result:
Resulted in a significant increase in faecal Cr excretion.
Animal Model:
Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model
Dosage:
10 mg/kg
Administration:
Administered via oral route just prior to induction of inflammation
Result:
Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h).